Heuts, B.M.H.; Arza-Apalategi, S.; Alkema, S.G.; Tijchon, E.; Jussen, L.; Bergevoet, S.M.; van der Reijden, B.A.; Martens, J.H.A.
Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation. Cells 2023, 12, 1195.
https://doi.org/10.3390/cells12081195
AMA Style
Heuts BMH, Arza-Apalategi S, Alkema SG, Tijchon E, Jussen L, Bergevoet SM, van der Reijden BA, Martens JHA.
Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation. Cells. 2023; 12(8):1195.
https://doi.org/10.3390/cells12081195
Chicago/Turabian Style
Heuts, Branco M. H., Saioa Arza-Apalategi, Sinne G. Alkema, Esther Tijchon, Laura Jussen, Saskia M. Bergevoet, Bert A. van der Reijden, and Joost H. A. Martens.
2023. "Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation" Cells 12, no. 8: 1195.
https://doi.org/10.3390/cells12081195
APA Style
Heuts, B. M. H., Arza-Apalategi, S., Alkema, S. G., Tijchon, E., Jussen, L., Bergevoet, S. M., van der Reijden, B. A., & Martens, J. H. A.
(2023). Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation. Cells, 12(8), 1195.
https://doi.org/10.3390/cells12081195
